Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and Neuromodulation

Patients with spina bifida and a neurogenic bladder have traditionally been managed with clean intermittent catheterization and pharmacotherapy in order to treat abnormal bladder wall dynamics, protect the upper urinary tract from damage, and achieve urinary continence. However, some patients will f...

Full description

Bibliographic Details
Main Authors: Jane M. Lewis, Earl Y. Cheng
Format: Article
Language:English
Published: Hindawi Limited 2007-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2007.178
id doaj-fad3de33b45b450a893205328f7bd826
record_format Article
spelling doaj-fad3de33b45b450a893205328f7bd8262020-11-25T02:40:28ZengHindawi LimitedThe Scientific World Journal1537-744X2007-01-0171230124110.1100/tsw.2007.178Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and NeuromodulationJane M. Lewis0Earl Y. Cheng1Children's Memorial Hospital, Feinberg School of Medicine Northwestern University, Chicago, IL, USAChildren's Memorial Hospital, Feinberg School of Medicine Northwestern University, Chicago, IL, USAPatients with spina bifida and a neurogenic bladder have traditionally been managed with clean intermittent catheterization and pharmacotherapy in order to treat abnormal bladder wall dynamics, protect the upper urinary tract from damage, and achieve urinary continence. However, some patients will fail this therapy and require surgical reconstruction in the form of bladder augmentation surgery using reconfigured intestine or stomach to increase the bladder capacity while reducing the internal storage pressure. Despite functional success of bladder augmentation in achieving a low pressure reservoir, there are several associated complications of this operation and patients do not have the ability to volitionally void. For these reasons, alternative treatments have been sought. Two exciting alternative approaches that are currently being investigated are tissue engineering and neuromodulation. Tissue engineering aims to create new bladder tissue for replacement purposes with both “seeded” and “unseeded” technology. Advances in the fields of nanotechnology and stem cell biology have further enhanced these tissue engineering technologies. Neuromodulation therapies directly address the root of the problem in patients with spina bifida and a neurogenic bladder, namely the abnormal relationship between the nerves and the bladder wall. These therapies include transurethral bladder electrostimulation, sacral neuromodulation, and neurosurgical techniques such as selective sacral rhizotomy and artificial somatic-autonomic reflex pathway construction. This review will discuss both tissue engineering techniques and neuromodulation therapies in more detail including rationale, experimental data, current status of clinical application, and future direction.http://dx.doi.org/10.1100/tsw.2007.178
collection DOAJ
language English
format Article
sources DOAJ
author Jane M. Lewis
Earl Y. Cheng
spellingShingle Jane M. Lewis
Earl Y. Cheng
Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and Neuromodulation
The Scientific World Journal
author_facet Jane M. Lewis
Earl Y. Cheng
author_sort Jane M. Lewis
title Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and Neuromodulation
title_short Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and Neuromodulation
title_full Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and Neuromodulation
title_fullStr Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and Neuromodulation
title_full_unstemmed Non-Traditional Management of the Neurogenic Bladder: Tissue Engineering and Neuromodulation
title_sort non-traditional management of the neurogenic bladder: tissue engineering and neuromodulation
publisher Hindawi Limited
series The Scientific World Journal
issn 1537-744X
publishDate 2007-01-01
description Patients with spina bifida and a neurogenic bladder have traditionally been managed with clean intermittent catheterization and pharmacotherapy in order to treat abnormal bladder wall dynamics, protect the upper urinary tract from damage, and achieve urinary continence. However, some patients will fail this therapy and require surgical reconstruction in the form of bladder augmentation surgery using reconfigured intestine or stomach to increase the bladder capacity while reducing the internal storage pressure. Despite functional success of bladder augmentation in achieving a low pressure reservoir, there are several associated complications of this operation and patients do not have the ability to volitionally void. For these reasons, alternative treatments have been sought. Two exciting alternative approaches that are currently being investigated are tissue engineering and neuromodulation. Tissue engineering aims to create new bladder tissue for replacement purposes with both “seeded” and “unseeded” technology. Advances in the fields of nanotechnology and stem cell biology have further enhanced these tissue engineering technologies. Neuromodulation therapies directly address the root of the problem in patients with spina bifida and a neurogenic bladder, namely the abnormal relationship between the nerves and the bladder wall. These therapies include transurethral bladder electrostimulation, sacral neuromodulation, and neurosurgical techniques such as selective sacral rhizotomy and artificial somatic-autonomic reflex pathway construction. This review will discuss both tissue engineering techniques and neuromodulation therapies in more detail including rationale, experimental data, current status of clinical application, and future direction.
url http://dx.doi.org/10.1100/tsw.2007.178
work_keys_str_mv AT janemlewis nontraditionalmanagementoftheneurogenicbladdertissueengineeringandneuromodulation
AT earlycheng nontraditionalmanagementoftheneurogenicbladdertissueengineeringandneuromodulation
_version_ 1724781467648655360